30 closest matches · ranked by relevance
Safer Conception Intervention Trial
Primary: Number of Participants Who Used Dual Contraception or Safer Conception Method — 35; 19; 9 Participants
HIV · Pregnancy
Primary: Dried Blood Spot Analysis of Medication Adherence- Mother and Infant — 56; 157; 35; 183 Participants
IPV · Sexual Violence
Primary: Any Past Year Physical Intimate Partner Violence Perpetration (Men) and Experience (Women) — 134; 86; 155; 118 Participants — p==0.686
Sexually Transmitted Infections
Primary: Number of Unprotected Acts of Intercourse — 19.7; 12.9; 18.2 # of unprotected sex acts at 12 months
Contraceptive Usage · Unintended Pregnancy
Primary: Percentage Change in Current Modern Contraceptive Use — -1.1; 1.4; 1.5 percentage of participants
Sexual Behavior · Intimate Partner Violence
Primary: Number of Participants With Satisfaction With Intervention Content — 28 Participants
Sexually Transmitted Diseases · Reproductive Behavior
Primary: Number of Participants With Uptake of 1 or More Health Services — 43; 33 Participants
Self Efficacy · HIV Prevention · STI Prevention
Primary: Change in Prevention Self-efficacy — 1.87; 0.20 score on a scale — p=0.04
Sexually Transmitted Infection · Alcohol Use Complicating the Puerperium · Alcohol Use Complicating Pregnancy, Unspecified Trimester
Primary: Unprotected Sexual Occasions (USOs) — 27.73; 41.50; 8.68; 14.70 USOs per participant — p=0.2964
HIV · Opioid Dependence
Primary: Demonstrated Drug Risk Reduction Skills (0-100%) — 40.60; 42.75 Percentage of correct steps
HIV · HIV Infections
Primary: Combined HIV/STI 12-month Incidence Rates of HIV, Syphilis, Chlamydia, Gonorrhea and Trichomonas Vaginalis. — 65.02; 67.66; 35.02; 54.04 incidence density per 100 person…
Substance Use
Primary: Alcohol Use — 1.37; 0.92 units on a scale
Contraception · Adolescent Behavior · Emergency Department
Primary: Adolescent Feasibility of Intervention — 4.5; 4.7 score on a scale
Contraception · Unintended Pregnancy
Primary: Unintended Pregnancy — 46; 25 Participants
Substance Abuse, Intravenous · HIV · Heroin Dependence
Primary: People Initiated Into Injection Drug Use — 2.05; 3.26 People initiated — p=0.35
PSA · Unprotected Sex
Primary: Number of Female Participants With Positive PSA at 2-Month Visit — 18; 20 Participants
Feasibility Studies
Primary: Acceptability Quantitative — 3.9; 3.8 score on a scale — p=<0.05
Contraception · Decision Making · Satisfaction
Primary: Decisional Conflict Scale Score — 15; 10; 0; 0 score on a scale
Ischemic Stroke · Intracranial Hemorrhage · Transient Ischemic Attack
Primary: Feasibility of Intervention (Ability to Reach Patients at 3 Months) — 16; 10 number of patients contacted
Foetal Exposure During Pregnancy
Primary: Number of Participants Reporting Risky Alcohol Use — 99; 86; 60; 48 Participants
Suicide · Accidental Injuries · Firearm Injury
Primary: Feasibility of the Intervention — 18; 40 Participants
Alcohol Abuse · Tobacco Use Disorder · Marijuana Abuse
Primary: Days Per Month of Primary Substance Use — 23.2; 23.7; 24.2; 19.3 days per month — p=<0.001
Suicide · Self Harm
Primary: Percentage of Eligible Participants Recruited to the Study — 87.2 Percentage of eligible participants
Maternal Behavior · Alcohol Drinking · Fetal Conditions
Primary: Number of Participants With Negative Urinalysis for Alcohol Metabolite (EtG) — 44 Participants
HIV-1 Virologic Response
Primary: Percentage of Participants Retained and Virally Suppressed Among Those Receiving the DTP Versus ICM Arms — 16.0; 14.1 percentage of participants — p=0.455
Human Immunodeficiency Virus
Primary: Number of Couples Who Tested for HIV as a Couple After Study Enrollment up to 12 Months Postpartum — 114; 106; 26 Couples tested for HIV as a couple (=Y) — p=<0.001
Human Immunodeficiency Virus · Acquired Immunodeficiency Syndrome · HIV Infections
Primary: Self-reported HIV Testing — 65.6; 31.3 percentage of participants
Hiv
Primary: Number of Women Retained in Care — 160; 164 Participants
Contraceptive Usage · Contraception
Primary: Current Use of Highly Effective Contraception — 2; 17 Participants
Patient Adherence · HIV Seronegativity
Primary: Adherence to PrEP — 85.6; 91.7; 81.6; 83.4 % participants with > 719 fmol/punch